MRI can detect nigral volume loss in patients with Parkinson's disease: evidence from a meta-analysis.
暂无分享,去创建一个
Ryuji Kaji | Yuishin Izumi | R. Kaji | W. Sako | Y. Izumi | Wataru Sako | Nagahisa Murakami | N. Murakami
[1] Yoshiharu Tamakawa,et al. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. , 2002, AJNR. American journal of neuroradiology.
[2] Suzanne Corkin,et al. Substantia nigra volume loss before basal forebrain degeneration in early Parkinson disease. , 2013, JAMA neurology.
[3] O. Paulson,et al. Increased intracranial volume in Parkinson's disease , 2005, Journal of the Neurological Sciences.
[4] J. Gore,et al. Using High-Resolution MR Imaging at 7T to Evaluate the Anatomy of the Midbrain Dopaminergic System , 2011, American Journal of Neuroradiology.
[5] A. Cerasa,et al. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. , 2011, Parkinsonism & related disorders.
[6] David J Brooks,et al. Parkinson's disease: diagnosis. , 2012, Parkinsonism & related disorders.
[7] David Eidelberg,et al. Milestones in neuroimaging , 2011, Movement disorders : official journal of the Movement Disorder Society.
[8] Paul M. Matthews,et al. Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease , 2010, NeuroImage.
[9] Chi-Shing Zee,et al. Magnetic Resonance Imaging-Based Volumetric Analysis of Basal Ganglia Nuclei and Substantia Nigra in Patients with Parkinson’s Disease , 2006, Neurosurgery.
[10] R P Maguire,et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. , 1997, Brain : a journal of neurology.
[11] Kevin J. Black,et al. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease , 2008, Brain and Cognition.
[12] L. Minati,et al. Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging. , 2007, AJNR. American journal of neuroradiology.
[13] Anna Barnes,et al. FDG PET in the differential diagnosis of parkinsonian disorders , 2005, NeuroImage.
[14] Hansjürgen Bratzke,et al. Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.
[15] T. Hosoya,et al. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. , 1999, AJNR. American journal of neuroradiology.
[16] Yong-Hee Han,et al. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy , 2013, Journal of Neurology.
[17] Z. Cho,et al. Seven‐tesla magnetic resonance images of the substantia nigra in Parkinson disease , 2012, Annals of neurology.
[18] Stéphane Lehéricy,et al. Magnetic resonance imaging of the substantia nigra in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[19] K. Kashihara,et al. Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease , 2011, Journal of Clinical Neuroscience.
[20] Oury Monchi,et al. Regional Brain Stem Atrophy in Idiopathic Parkinson's Disease Detected by Anatomical MRI , 2009, PloS one.
[21] Richard S. J. Frackowiak,et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography , 1992, Annals of neurology.
[22] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[23] M. McKeown,et al. Advances in imaging in Parkinson's disease , 2011, The Lancet Neurology.
[24] D. Dickson. Parkinson's disease and parkinsonism: neuropathology. , 2012, Cold Spring Harbor perspectives in medicine.